Skip to Content

CNN – Health

Vaccine advisers to the US Centers for Disease Control and Prevention voted on Thursday to recommend booster doses of both Moderna's and Johnson & Johnson Covid-19 vaccines.

CDC endorses booster doses of Moderna and Johnson & Johnson vaccines, says mix and match is fine

By Maggie Fox, CNN US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky endorsed recommendations for booster doses for Moderna’s and Johnson & Johnson’s coronavirus vaccines Thursday, allowing millions more Americans to begin getting booster shots. Walensky also endorsed the mix-and-match approach to boosters, saying eligible people could choose whichever vaccine they wished

Continue Reading
A Safeway pharmacist prepares to give a Pfizer COVID-19 booster vaccination at a vaccination booster shot clinic on October 01

Booster dose of Pfizer/BioNTech coronavirus vaccine shows 95.6% efficacy in Phase 3 trial, companies say

By Jacqueline Howard, CNN A booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — against Covid-19 in a Phase 3 trial, the companies announced on Thursday. They noted that “efficacy was consistent irrespective of age, sex, race, ethnicity or comorbid conditions.” The trial included more than 10,000

Continue Reading
There are easy steps you can use to identify and then treat stress.

5 expert tips to stress less this fall

By Sandee LaMotte, CNN As we head into what was supposed to be the fall recovery, the world is still reeling from Covid-related anxiety. It shows up in tepid job recovery and stock market tremors as well as in disagreements over masks and vaccine requirements in our schools and communities. It’s not just Covid–19 that’s

Continue Reading
A 13-year-old newly vaccinated against COVID-19 shows his bandage at a pop-up vaccination site on June 5

Pfizer vaccine is 93% effective in preventing Covid-19 hospitalization among adolescents, CDC study finds

By Deidre McPhillips, CNN The Pfizer/BioNTech vaccine is 93% effective in preventing hospitalization due to Covid-19 among children ages 12 to 18, according to a study by the US Centers for Disease Control and Prevention. Vaccine effectiveness differed only slightly within that age group, with 91% effectiveness for children age 12 to 15 and 94%

Continue Reading